🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Increased Dietary Protein Intake During GLP-1 Medication Use (in Middle-aged Women With Overweight/Obesity)

RecruitingNAAges 30 Years - 60 YearsFemaleUniversity of Texas at Austin
NCT07480109 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Middle-aged women with (overweight/)obesity who will begin or have begun GLP-1 medication use will be recruited to complete a 12-week diet intervention study. For 12-weeks, participants will continue to take their GLP-1 medication and may be provided with protein-rich foods to consume every day. Body composition, eating behavior, health, and well-being will be measured before and after the study.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Adult women (30-60 years) * Having overweight or obesity (BMI \>25 kg/m2) * Prescribed or taking GLP-1 medicine (within 4 weeks) by a physician * Willing and able to maintain current inactivity patterns throughout the study * Willing and able to follow all study procedures * Generally healthy, as assessed from the medical history questionnaire Exclusion Criteria: * Adults (\<30 years or \>60 years) * Having normal weight (BMI \<25 kg/m2) * Not prescribed GLP-1 medication by a physician * Those on GLP-1 medication longer than 4 weeks (during time of screening) * Currently on a high-protein or other specific diet * Unwilling and/or unable to maintain current inactivity patterns throughout the study * Unwilling and/or unable to follow all study procedures * Unwilling and/or unable to eat pork (for the GLP-1 + Protein group) * Not generally healthy, as assessed from the medical history questionnaire
💊

What it tests

  • Protein Rich Foods
📍

Where

2 sites
Dell Pediatric Research Center
Austin, United States
University of Texas at Austin
Austin, United States
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy